Global Portable Ultrasound Equipment Market to Reach USD 2.5 Billion by 2026
|
By MedImaging International staff writers Posted on 01 Jul 2021 |

Image: The vScan handheld ultrasound device (Photo courtesy of GE Healthcare)
The global portable ultrasound equipment market is projected to grow at a CAGR of 6.3% from USD 1.7 billion in 2020 to USD 2.5 billion by 2026, driven primarily by an increasing number of application areas, rising prevalence of diseases, and growing technological advancements.
These are the latest findings of a new market study published by Global Industry Analysts Inc. (San Francisco, CA, USA), a market research company.
Portable ultrasound machines, in general are ideal for small hospitals, PCP offices, obstetric practices, sports medicine clinics, small physician practice and independent clinics. By delivering relative ease in its operation, portable ultrasound devices have the potential to capture significant share in the point-of-care imaging market. Portable ultrasound devices are proving to be extremely useful in applications where space is the constraint and also where mobility of devices is required for example if scanning is required to be carried out on the field.
Portable ultrasound devices are increasingly used in various areas such as musculoskeletal, critical care medicine, and emergency medicine. Adoption of these devices has grown considerably on account of rising number of minimally invasive procedures and for prenatal and antenatal care of mothers who lack access to big healthcare facilities. They are also finding widespread use in urinary bladder dysfunction, abdominal evaluations, gallbladder visualization, DVT surveillance, and vascular access. Increasing AI integration in ultrasound devices, which provide the units with better diagnostics capability is another major factor promoting market growth.
On the basis of product type, the Cart/Trolley-based segment is projected to grow at a 6.4% CAGR to reach USD 2.5 billion by the end of the analysis period while the Handheld segment is expected to record a 4.8% CAGR for the next 7-year period. The Handheld segment currently accounts for a share of 8.1% of the global portable ultrasound equipment market. In terms of applications, cardiologists, intensivists, and emergency medicine physicians have been some of the initial users of handheld ultrasound systems. Over the years, supported by the integration of advanced features, the devices have also gained acceptance among anesthesia, procedural ultrasound, and other specialists.
Geographically, the US currently accounts for a share of 32.52% of the global portable ultrasound equipment market and is estimated to be valued at USD 590.9 million in 2021. China’s portable ultrasound equipment market is forecasted to record a CAGR of 8% through the analysis period to reach an estimated USD 257.5 million in 2026. The portable ultrasound equipment market in Japan and Canada are forecasted to grow at 5.4% and 5.7%, respectively over the analysis period. Within Europe, the portable ultrasound equipment market in Germany is forecasted to grow at approximately 5.9% CAGR while the market in Rest of Europe is expected to reach USD 279.3 million by the end of the analysis period. The developed economies account for a major share of the global portable ultrasound equipment market due to increasing prevalence of various diseases, well-developed healthcare infrastructure, easy reimbursement, and government support for technological developments. Economic growth, increasing healthcare spending, improved standard of healthcare facilities are expected to fuel the demand for new equipment in the developing markets.
Related Links:
Global Industry Analysts Inc.
These are the latest findings of a new market study published by Global Industry Analysts Inc. (San Francisco, CA, USA), a market research company.
Portable ultrasound machines, in general are ideal for small hospitals, PCP offices, obstetric practices, sports medicine clinics, small physician practice and independent clinics. By delivering relative ease in its operation, portable ultrasound devices have the potential to capture significant share in the point-of-care imaging market. Portable ultrasound devices are proving to be extremely useful in applications where space is the constraint and also where mobility of devices is required for example if scanning is required to be carried out on the field.
Portable ultrasound devices are increasingly used in various areas such as musculoskeletal, critical care medicine, and emergency medicine. Adoption of these devices has grown considerably on account of rising number of minimally invasive procedures and for prenatal and antenatal care of mothers who lack access to big healthcare facilities. They are also finding widespread use in urinary bladder dysfunction, abdominal evaluations, gallbladder visualization, DVT surveillance, and vascular access. Increasing AI integration in ultrasound devices, which provide the units with better diagnostics capability is another major factor promoting market growth.
On the basis of product type, the Cart/Trolley-based segment is projected to grow at a 6.4% CAGR to reach USD 2.5 billion by the end of the analysis period while the Handheld segment is expected to record a 4.8% CAGR for the next 7-year period. The Handheld segment currently accounts for a share of 8.1% of the global portable ultrasound equipment market. In terms of applications, cardiologists, intensivists, and emergency medicine physicians have been some of the initial users of handheld ultrasound systems. Over the years, supported by the integration of advanced features, the devices have also gained acceptance among anesthesia, procedural ultrasound, and other specialists.
Geographically, the US currently accounts for a share of 32.52% of the global portable ultrasound equipment market and is estimated to be valued at USD 590.9 million in 2021. China’s portable ultrasound equipment market is forecasted to record a CAGR of 8% through the analysis period to reach an estimated USD 257.5 million in 2026. The portable ultrasound equipment market in Japan and Canada are forecasted to grow at 5.4% and 5.7%, respectively over the analysis period. Within Europe, the portable ultrasound equipment market in Germany is forecasted to grow at approximately 5.9% CAGR while the market in Rest of Europe is expected to reach USD 279.3 million by the end of the analysis period. The developed economies account for a major share of the global portable ultrasound equipment market due to increasing prevalence of various diseases, well-developed healthcare infrastructure, easy reimbursement, and government support for technological developments. Economic growth, increasing healthcare spending, improved standard of healthcare facilities are expected to fuel the demand for new equipment in the developing markets.
Related Links:
Global Industry Analysts Inc.
Latest Industry News News
- Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
- GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
- Patient-Specific 3D-Printed Phantoms Transform CT Imaging
- Siemens and Sectra Collaborate on Enhancing Radiology Workflows
- Bracco Diagnostics and ColoWatch Partner to Expand Availability CRC Screening Tests Using Virtual Colonoscopy
- Mindray Partners with TeleRay to Streamline Ultrasound Delivery
- Philips and Medtronic Partner on Stroke Care
- Siemens and Medtronic Enter into Global Partnership for Advancing Spine Care Imaging Technologies
- RSNA 2024 Technical Exhibits to Showcase Latest Advances in Radiology
- Bracco Collaborates with Arrayus on Microbubble-Assisted Focused Ultrasound Therapy for Pancreatic Cancer
- Innovative Collaboration to Enhance Ischemic Stroke Detection and Elevate Standards in Diagnostic Imaging
- RSNA 2024 Registration Opens
- Microsoft collaborates with Leading Academic Medical Systems to Advance AI in Medical Imaging
- GE HealthCare Acquires Intelligent Ultrasound Group’s Clinical Artificial Intelligence Business
- Bayer and Rad AI Collaborate on Expanding Use of Cutting Edge AI Radiology Operational Solutions
- Polish Med-Tech Company BrainScan to Expand Extensively into Foreign Markets
Channels
Radiography
view channel
AI Boosts Breast Cancer Detection and Cuts Screening Workload
Breast cancer screening programs face rising demand and persistent workforce shortages, straining double-reading workflows and delaying care. Early detection is critical to reduce mortality and minimize... Read more
AI Tool Predicts Breast Cancer Risk Years Ahead Using Routine Mammograms
Breast cancer screening saves lives but still relies largely on uniform schedules despite wide differences in individual risk. This one-size-fits-all approach can miss cancers in higher-risk women while... Read moreMRI
view channel
Study Finds Advanced Imaging Significantly Reduces Unnecessary Prostate Biopsies
Many men with suspected prostate cancer face an invasive biopsy when magnetic resonance imaging (MRI) is inconclusive. Biopsies can be uncomfortable, carry risks, and may contribute to overdiagnosis and... Read more
New Material Boosts MRI Image Quality
Magnetic resonance imaging (MRI) is a cornerstone of modern diagnostics, yet certain deep or anatomically complex tissues, including delicate structures of the eye and orbit, remain difficult to visualize clearly.... Read moreUltrasound
view channel
New Consensus Standardizes Ultrasound-Based Fatty Liver Assessment
Metabolic dysfunction-associated steatotic liver disease (MASLD) is rising along with obesity and diabetes, making accurate, scalable measurement of hepatic fat a clinical priority. Biopsy is invasive... Read more
Groundbreaking Technology to Enhance Precision in Emergency and Critical Care
Rapid and accurate imaging is essential for diagnosing life-threatening conditions such as myocardial infarction, heart failure, and pulmonary embolism. However, conventional ultrasound imaging of the... Read moreNuclear Medicine
view channel
PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing pancreatic beta cells. Loss of these cells destabilizes glucose control and drives complications.... Read more
New Imaging Tool Sheds Light on Tumor Fat Metabolism
Rapidly growing tumors reprogram metabolism to meet high energy demands. While many cancers preferentially consume glucose, lipid utilization by malignant cells is difficult to measure in living subjects.... Read more
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read moreGeneral/Advanced Imaging
view channel
AI Tool Predicts Side Effects from Lung Cancer Treatment
Radiation therapy is a central treatment for lung cancer, but even carefully targeted radiation can affect surrounding healthy tissue. Patients may develop side effects such as lung inflammation, coughing,... Read more
AI Tool Offers Prognosis for Patients with Head and Neck Cancer
Oropharyngeal cancer is a form of head and neck cancer that can spread through lymph nodes, significantly affecting survival and treatment decisions. Current therapies often involve combinations of surgery,... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
Clinical imaging services face rising demand for precise molecular diagnostics and targeted radiopharmaceutical therapy as cancer and chronic disease rates climb. A new market analysis projects rapid expansion... Read more







